# Community-Level Screening and Referral Guidelines for Major Non-Communicable Diseases at Primary Healthcare Settings: From Development to Application at the Multi-site ‘NCDs Mega-Campaign 2024’ in Kathmandu Metropolitan City, Nepal

**Authors:** Milan Malla, Richa Nepal, Sushant Regmi, Deewash Neupane, Dhanendra Shrestha, Saugat Bhandari, Madhusudan Subedi

PMC · DOI: 10.31729/jnma.8955 · JNMA: Journal of the Nepal Medical Association · 2025-04-30

## TL;DR

This paper describes a community-based screening program for hypertension, diabetes, and CKD in Nepal, implemented across 256 sites in Kathmandu in 2024.

## Contribution

The study introduces structured, community-focused guidelines for NCD screening and referral in primary healthcare settings in Nepal.

## Key findings

- A three-phase program was developed and applied across 256 sites in Kathmandu for NCD screening.
- The initiative aimed to address the rising undiagnosed NCD burden in lower- and middle-income countries.
- The guidelines were designed to improve people-centric strategies and community-focused interventions.

## Abstract

Non-communicable diseases (NCDs), mainly cardiovascular conditions like hypertension, diabetes, and chronic kidney disease (CKD) are the major causes of morbidities and mortalities worldwide, with lower- and middle-income countries (LMICs) bearing the highest burden. As the UN 25*25 targets near their final year and the Sustainable Development Goals approach their last trimester, NCD cases continue to rise, leaving a significant undiagnosed population submerged in the communities and households. In Nepal, a few initiatives have been made at the health-facility level over the past decade. However, they lack people-centric strategies and community-focused intervention with appropriate working guidelines. This article outlines the three-phase development of a community-level screening program in Kathmandu Metropolitan City, providing structured guidelines for health workers to screen and appropriately refer cases of hypertension, diabetes, and CKD, implemented during the large-scale community-based campaigns across 256 sites in Kathmandu Metropolitan in 2024.

## Linked entities

- **Diseases:** diabetes (MONDO:0005015), chronic kidney disease (MONDO:0005300)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** hyperglycemia (MESH:D006943), chronic respiratory diseases (MESH:D012140), deaths (MESH:D003643), Hypertension (MESH:D006973), cancer (MESH:D009369), Diabetes (MESH:D003920), CVDs (MESH:D002318), kidney failure (MESH:D051437), CKD (MESH:D051436), Kidney Disease (MESH:D007674), heart failure (MESH:D006333), heart disease (MESH:D006331), NCDs (MESH:D000073296), stroke (MESH:D020521), chronic lung disease (MESH:D029424), DEVELOPING (MESH:D002658), -communicable Diseases (MESH:D003141)
- **Chemicals:** fats (MESH:D005223), salt (MESH:D012492), urea (MESH:D014508), alcohol (MESH:D000438), blood sugar (MESH:D001786), creatinine (MESH:D003404)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12831850/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12831850/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12831850/full.md

---
Source: https://tomesphere.com/paper/PMC12831850